Statement of Retraction: Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Gynecological Endocrinology |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2023.2272094 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statement of Retraction: Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial
Published: (2024-12-01) -
Clomiphene Citrate versus Clomiphene Citrate in combination with other drugs in Ovulation Induction in Patients with Polycystic Ovary Syndrome
by: Mostafa Khodary, et al.
Published: (2025-07-01) -
Statement of Retraction: L-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial
Published: (2024-12-01) -
Statement of retraction: Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial
Published: (2024-12-01) -
Successful Advanced Maternal Age Pregnancy with Mosaic Turner Syndrome Conceived after Ovulation Induction with Clomiphene Citrate: A Case Report
by: Masahiro Murakami, et al.
Published: (2014-01-01)